Pharmacokinetics and Metabolism of the Plant Cannabinoids 683of daily cannabis users had positive cannabinoid hair tests by GC/MS/MS with de-
tection limits of 1 ng/mg for THC and 0.1 ng/mg for THCCOOH. All participants
had positive urine cannabinoid tests at the time of hair collection (unpublished
data).
References
Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and hu-
mans. Addiction 91:1585–1614
Agurell S, Leander K (1971) Stability, transfer and absorption of cannabinoid constituents
of cannabis (hashish) during smoking. Acta Pharm Suec 8:391–402
Agurell S, Gillespie H, Halldin M, Hollister LE, Johansson E, Lindgren JE, Ohlsson A,
Szirmai M, Widman M (1984) A review of recent studies on the pharmacokinetics and
metabolism of delta-1-tetrahydrocannabinol, cannabidiol and cannabinol in man. In:
Paton SW, Nahas GG (eds) Marijuana ’84. IRL Press, Oxford, pp 49–62
Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L (1986)
Pharmacokinetics and metabolism of delta-tetrahydrocannabinol and other cannabi-
noids with emphasis on man. Pharmacol Rev 38:21–43
Atkinson HC, Begg EJ, Darrlow BA (1988) Drugs in human milk clinical pharmacokinetic
considerations. Clin Pharmacokinet 14:217–240
Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM (1992) Marijuana smoking: effect of
varying delta 9-tetrahydrocannabinol content and number of puffs. J Pharmacol Exp
Ther 261:114–122
Bailey JR, Cunny HC, Paule M, Slikker W Jr (1987) Fetal disposition of delta-9-tetrahydro-
cannbinol (THC) during late pregnancy in the rhesus monkey. Toxicol Appl Pharmacol
90:315–321
Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L (2000)
Cannabinoidscontrolspasticityandtremorinamultiplesclerosismodel.Nature404:84–
87
Balabanova S, Schneider E (1989) Nachweis von drogen im schweis. Beitr Gerichtl Med
48:45–49
Ben-Zvi Z, Burstein S (1974) 7-Oxo-delta-1-tetrahydrocannabinol: a novel metabolite of
delta 1 tetrahydrocannabinol. Int J Clin Pharmacol Ther 8:223–229
Ben-Zvi Z, Bergen JR, Burstein S, Sehgal PK, Varanelli C (1976) The metabolism of delta-
tetrahydrocannabinol in the rhesus monkey. In: Braude MC, Szara S (eds) The pharma-
cology of marijuana. Raven Press, New York, pp 63–75
Benowitz NL, Nguyen TL, Jones RT, Herning RI, Bachman J (1980) Metabolic and psy-
chophysiologic studies of cannabidiol-hexobarbital interaction. Clin Pharmacol Ther
28:115–117
Binitie A (1975) Psychosis following ingestion of hemp in children. Psychopharmacologia
44:301–302
Blackard C, Tennes K (1984) Human placental transfer of cannabinoids. N Engl J Med
311:797
Blanc JA, Manneh VA, Ernst R, Berger DE, de Keczer SA, Chase C, Centofanti JM, DeLizza
AJ (1993) Adsorption losses from urine-bases cannabinoid calibrators during routine
use. Clin Chem 39:1705–1717
Bloom AS (1982) Effect of delta-9-tetrahydrocannabinol on the synthesis of dopamine and
norepinephrine in mouse brain synaptosomes. J Pharmacol Exp Ther 221:97–103
Bornheim LM, Lasker JM, Raucy JL (1992) Human hepatic microsomal metabolism of
delta-1-tetrahydrocannabinol. Drug Metab Dispos 20:241–246
Brenneisen R, Egli A, ElSohly MA, Henn V, Spiess Y (1996) The effect of orally and rectally
administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
Int J Clin Pharmacol Ther 34:446–452